Shuangdeng Group Schedules Board Meeting for 2025 Annual Results Approval

Shuangdeng Group Co., Ltd. (Stock Code: 06960), a leading joint stock company incorporated in the People’s Republic of China, has officially announced that its Board of Directors will convene on Wednesday, March 25, 2026. The primary agenda of this meeting is to consider and approve the annual financial results for the fiscal year ended December 31, 2025.

Key Points from the Announcement

• Board Meeting Date: The pivotal board meeting is scheduled for March 25, 2026.
• Annual Results Approval: The Board will review and approve the audited financial statements and performance of the Company and its subsidiaries for the year ended December 31, 2025.
• Final Dividend Recommendation: The Board will also consider whether to recommend the payment of a final dividend to shareholders. The final dividend decision can have a direct impact on shareholder returns and may influence the Company’s stock price.
• Other Business: The Board may also transact other significant business items during this meeting, which could include strategic decisions or corporate actions.

Why This Matters for Shareholders

• Potential Price Sensitivity: The approval and subsequent publication of the annual results are key events that can influence investor sentiment and the market value of Shuangdeng Group’s shares. Any significant changes in revenue, profit, or dividend payout can result in notable share price movements.
• Dividend Consideration: The possibility of a final dividend is of particular importance to current and prospective shareholders, as dividends are a direct return on investment. The Board’s recommendation, if any, will be closely watched by the market.
• Additional Board Business: While not specified, any strategic decisions or other corporate actions announced alongside the results could further impact share price direction.

Details of the Board Composition

The Board of Directors comprises a mix of executive, non-executive, and independent non-executive directors, reflecting a strong governance structure:

• Dr. Yang Rui – Chairman, Executive Director, and CEO
• Dr. Yang Baofeng – Executive Director
• Ms. He Rong – Executive Director
• Mr. Qian Shan’gao – Non-Executive Director
• Dr. Yin Junming – Independent Non-Executive Director
• Dr. Wang Jin – Independent Non-Executive Director
• Dr. Wang Xi – Independent Non-Executive Director

What Investors Should Watch For

• Investors should pay close attention to the release of the annual results and any accompanying statements about the Company’s performance, outlook, and dividend policy.
• Shareholders are advised to monitor any other potential announcements resulting from the board meeting that may affect the Company’s future strategic direction.

This announcement was made on March 10, 2026.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors are advised to conduct their own due diligence or consult with a professional advisor before making any investment decisions relating to Shuangdeng Group Co., Ltd.

View SHUANGDENG Historical chart here